Outset Medical Inc (OM)
3.73
+0.19
(+5.37%)
USD |
NASDAQ |
May 31, 16:00
3.73
0.00 (0.00%)
After-Hours: 20:00
Outset Medical Cash from Financing (TTM): 106.98M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 106.98M |
December 31, 2023 | 43.65M |
September 30, 2023 | 76.02M |
June 30, 2023 | 74.45M |
March 31, 2023 | 74.45M |
December 31, 2022 | 72.90M |
September 30, 2022 | 8.232M |
Date | Value |
---|---|
June 30, 2022 | 11.89M |
March 31, 2022 | 161.65M |
December 31, 2021 | 160.15M |
September 30, 2021 | 158.34M |
June 30, 2021 | 411.91M |
March 31, 2021 | 261.13M |
December 31, 2020 | 385.68M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
8.232M
Minimum
Sep 2022
411.91M
Maximum
Jun 2021
143.39M
Average
91.50M
Median
Cash from Financing (TTM) Benchmarks
Baxter International Inc | -3.257B |
AngioDynamics Inc | -59.25M |
Allurion Technologies Inc | 83.51M |
Perspective Therapeutics Inc | 167.19M |
Xtant Medical Holdings Inc | 20.30M |